Aurion Biotech, Inc. (AURN) has filed to raise $100 million in an IPO of its common stock, according to SEC S-1 registration information. The firm is commercializing and developing treatments for ...

A judge has ruled against investor Alcon Research on the matter of blocking investee Aurion Biotech from debuting on the public market, a decision Alcon says it will move to appeal. Cell therapy ...

Slithering into the heart of mythology, religion and folklore worldwide, snakes have long either been revered as divine messengers or feared as harbingers of doom. In ancient Egypt, a rearing ...

In­vestors typ­i­cal­ly cel­e­brate IPOs as mile­stone mo­ments — and po­ten­tial ex­it op­por­tu­ni­ties — for their star­tups.

Cell therapy company Aurion Biotech is moving forward with plans to IPO despite a pending lawsuit from one of its existing investors. The eye-disease-focused company plans to list on the New York ...